Alba Therapeutics has appointed Bruce Peacock as CEO and a member of its board of directors. Mr Peacock is a venture partner with SV Life Sciences Advisors.
Subscribe to our email newsletter
Previously, Mr Peacock served as the CEO or was a member of the senior management team for several successful entrepreneurial healthcare companies operating in therapeutic, diagnostic and service areas including the Little Clinic, Adolor, Orthovita, Cephalon, and Centocor.
The company also announced that Blake Paterson, Alba’s CEO and co-founder since its inception in 2004, has left the company to pursue other advisory and entrepreneurial interests.
Dan Janney, board of director at Alba, said: “Mr Peacock brings a wealth of experience and leadership with a proven track record of success. His experience in leading successful research and development and commercial infrastructures will be invaluable to Alba.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.